USA: Morningstar Law Group welcomes Ben Martie26 July 2022
Ben Martie is a seasoned life sciences attorney and industry expert with unique insight and a deep understanding of the needs of pharmaceutical, biotechnology, medical device, and other life sciences companies.
Ben's extensive experience includes serving as lead counsel on an array of matters, such as licensing deals, asset purchases, commercial transactions, manufacturing and supply agreements, wholesaler and distributor agreements, commercial launches, pricing, rebates and discounts, Sunshine Act/Open Payments reporting , promotional policies and practices, compliance programs, and internal investigations.
Ben also provides counsel to life sciences companies on a variety of laws and regulations administered and enforced by federal authorities, such as FDA, FTC, OIG, CMS, and DOJ, as well as state authorities, such as attorneys general, boards of pharmacy, departments of health, and others. Ben assists companies with development and administration of effective compliance programs, particularly with regard to applicable laws, regulations, agency guidance, and industry codes and standards, eg, PhRMA Code, AdvaMed Code.
Prior to joining the firm, Ben spent more than a decade as in-house counsel with both privately-held and publicly-traded pharmaceutical and life sciences companies in the Triangle. Most recently, Ben served as the General Counsel and Chief Compliance Officer for RedHill Biopharma, a commercial-stage pharmaceutical company.
Welcome also to the WLN, Ben!
For further information, please contact:
Randy Whitmeyer , Partner
Morningstar Law Group, Raleigh
t: +1 919 590 0369
#WLNadvocate #USA #MorningstarLawGroup #lawfirm #legal #welcome #counsel #attorney #pharmaceutical #lifescience #biotechnology